DEJIMA Infectious Disease Research Alliance (DIDA)
Nagasaki University
EN
JP
Home
About DIDA
From the President of Nagasaki University
From the Director of DIDA
Organization
Tokyo Office
Vaccine Research and Development Center
Home
About DIDA
From the President of Nagasaki University
From the Director of DIDA
Organization
Tokyo Office
Vaccine Research and Development Center
EN
JP
Nagasaki Dejima Illustration, drawn by KAWAHARA Keiga:owned by the Nagasaki University Library
Scroll
Topics
2025.10.3
Vaccine Research and Development Center
Research Highlights
Tropical Virus Pharmaceutical Research Team:Announcement on 「Epidemiological insights into the co-circulation of Zika and dengue viruses in Yangon, Myanmar (2017-2019)」 2025/9/24
2025.10.3
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「Potential health impact and cost-effectiveness of human papillomavirus vaccination in Tunisia: A comparative modeling study」 2025/9/9
2025.10.3
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「COVID-19 vaccine effectiveness and duration of protection among children and adolescents: A retrospective cohort study in 11 large cities in Japan」 2025/8/27
2025.10.3
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「Evaluating the effectiveness of international travel controls to identify MPXV-infected travelers: a simulation study」 2025/8/12
2025.10.3
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「Viral non-SARS-CoV-2 etiology of community-acquired pneumonia (CAP) in Southeast Asia: a review and pooled analysis」 2025/5/17
View all
2025.4.7
News
Professor Koichi Morita Receives the “For People’s Health” Medal from Vietnam’s Ministry of Health
2025.3.10
Nagasaki University Secures CEPI Funding to Develop AI-Driven Nanoball Vaccine Technology – Targeting mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome (SFTS)
2025.3.5
News
Visit from Sukraraj Tropical and Infectious Disease Hospital (STIDH), Kathmandu, Nepal
2024.3.12
Nagasaki University signed an MOU with the International Vaccine Institute (IVI)
2022.9.27
News
Events
Nagasaki University held a launching ceremony for the DEJIMA Infectious Disease Research Alliance and the National Research Center for the Control and Prevention of Infectious Diseases.
View all
2025.10.3
Research Highlights
Tropical Virus Pharmaceutical Research Team:Announcement on 「Epidemiological insights into the co-circulation of Zika and dengue viruses in Yangon, Myanmar (2017-2019)」 2025/9/24
2025.10.3
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「Potential health impact and cost-effectiveness of human papillomavirus vaccination in Tunisia: A comparative modeling study」 2025/9/9
2025.10.3
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「COVID-19 vaccine effectiveness and duration of protection among children and adolescents: A retrospective cohort study in 11 large cities in Japan」 2025/8/27
2025.10.3
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「Evaluating the effectiveness of international travel controls to identify MPXV-infected travelers: a simulation study」 2025/8/12
2025.10.3
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「Viral non-SARS-CoV-2 etiology of community-acquired pneumonia (CAP) in Southeast Asia: a review and pooled analysis」 2025/5/17
View all
PAGE TOP